Dan MacLeod

Dan joined ImmunoScape in 2021 and serves as Vice President, Discovery. He has over 15 years education and experience in Immunology, Oncology, Cancer, Immunotherapy, Gene-editing, and Virology. Before joining the ImmunoScape team, Dan spent 6 years at Precision BioSciences, focused on engineering human T cells for cancer therapy. He held several positions of escalating responsibility at Precision, including his final role as Senior Director, leading a team responsible for early-stage research to IND-enabling studies for four allogeneic gene-edited CAR T therapies that advanced into Phase I/II clinical studies. Prior to joining Precision, Dan was an investigator at GlaxoSmithKline working on immunomodulatory small molecule drug discovery programs. He also performed postdoctoral work at the International AIDS Vaccine Initiative Neutralizing Antibody Center at the Scripps Research Institute, and at the University of California, San Diego.

Dan received a B.A. from Northwestern University with a double major in biochemistry and psychology, and a Ph.D. in molecular pathology and biomedical sciences from the University of California, San Diego.